The document summarizes the discovery and mechanism of the CRISPR-Cas genome editing system. It describes how CRISPR sequences were initially discovered in bacteria and later found to provide adaptive immunity. The system works by integrating short DNA sequences from viruses/plasmids between repeat sequences. This allows the Cas proteins to recognize and cut invading DNA for degradation. The document outlines applications of CRISPR in gene knockout, knock-in, and interference in eukaryotic systems including potential medical uses.
The document summarizes the discovery and mechanism of the CRISPR-Cas genome editing system. It describes how CRISPR sequences were initially discovered in bacteria and later found to provide adaptive immunity. The system works by integrating short DNA sequences from viruses/plasmids between repeat sequences. This allows the Cas proteins to recognize and cut invading DNA for degradation. The document outlines applications of CRISPR in gene knockout, knock-in, and interference in eukaryotic systems including potential medical uses.
The document summarizes the discovery and mechanism of the CRISPR-Cas genome editing system. It describes how CRISPR sequences were initially discovered in bacteria and later found to provide adaptive immunity. The system works by integrating short DNA sequences from viruses/plasmids between repeat sequences. This allows the Cas proteins to recognize and cut invading DNA for degradation. The document outlines applications of CRISPR in gene knockout, knock-in, and interference in eukaryotic systems including potential medical uses.
The document summarizes the discovery and mechanism of the CRISPR-Cas genome editing system. It describes how CRISPR sequences were initially discovered in bacteria and later found to provide adaptive immunity. The system works by integrating short DNA sequences from viruses/plasmids between repeat sequences. This allows the Cas proteins to recognize and cut invading DNA for degradation. The document outlines applications of CRISPR in gene knockout, knock-in, and interference in eukaryotic systems including potential medical uses.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 13
CRISPR- CAS
SYSTEM
A powerful new tool for GENOME EDITIN
Submitted to: Dr. T.C.Bhalla
Submitted by: Meghna Garg R.NO: 3401
DISCOVERY OF CRISPR-CaS SYSTEM
In 1987, the first description of a CRISPR locus
was published by a lab which discovered a group of 29-nucleotide repeats divided by nonrepetitive short sequences in E. coli, which are now known as spacers (Ishino et al., 1987). Mojica et al. (2000) later determined that similar sequences of short regularly spaced repeats (SRSRs) are present in many species of bacteria. In 2002, Jansen et al. further defined these SRSRs as a group of repeats that is preceded by both aleader sequence and an AT-rich region.
The authors also found a conserved family of genes that
generally exist near the repeats. This family consisted of genes encoding proteins like DNA helicases (cas3) and exonucleases (cas4), which implied that Cas genes likely have function in DNA metabolism. They renamed the SRSRs as CRISPRs and the genes found near them as CRISPR-associated genes (Cas) (Jansen et al, 2002). Bolotin et al (2005) sequenced the CRISPR spacers of 24 strains of Streptococcus thermophilus and Streptococcus vestibularis and found that the sequences were homologous with extra-chromosomal elements. The authors theorized that CRISPR spacers are the heritable remnants of infection from exogenous DNA.
INTEGRATION OF SPACERS
MECHANISM OF FUNCTIONING
FINAL BINDING
APPLICATIONS IN EUKARYOTES
Recent work has proven that the CRISPR/Cas9
system can be utilized for gene editing in a plethora of systems including yeast, rice, zebra fish, mouse, and even humans.(Mali et al., 2013) Based on the type II CRISPR/Cas9 mechanism, researchers have engineered a RNA chimera of tracrRNA-crRNA called single guide RNA (sgRNA) which is able to cause sequence-specific binding to dsDNA (Cong et al, 2013). Cas9 nuclease is capable of interacting with this engineered sgRNA in order to specifically cleave dsDNA in regions complementary to the introduced sgRNA.
1.GENE KNOCK OUT AND 2. KNOCK IN
APPLICATIONS OF GENE KNOCK OUT
GENE KNOCK OUT SYSTEM: CRISPR could be used
to delete harmful disease causing mutations in the human genome, especially in IVF embryos. Alternatively, the system could be used to knockout specific genes in model organisms in order to study diseases. Multiple genes could be knocked out at the same time. Gene knockout system has been used effectively for knockout of AIDS virus. HOW?? ANSWER- target the LTRs instead of CCR5 proteins.
APPLICATIONS OF GENE KNOCK- IN
GENE KNOCK IN SYSTEM: Many genetic diseases
could be cured by modifying genomic sequences of pluripotent stem cells of patients to express wildtype copies of the disease causing genes. This would allow for autologous stem cell therapies which reduces the risk of graft-host disease. Schwank et al, studied the use of CRISPR gene knock-in as a therapy for Cystic Fibrosis. They succeeded in correcting mutant CFTR DeltaF508 alleles (alleles with a mutation that causes cystic fibrosis) using the CRISPR/Cas9 mediated homologous recombination in intestinal stem cells.
CRISPR INTERFERENCE
In 2013, Qi et al. created a catalytically dead Cas9
(dCas9), lacking endonuclease activity, in order to function in gene silencing as opposed to gene editing through DSBs. This method, called CRISPR interference (CRISPRi) halts mRNA synthesis by blocking RNA polymerase at the promoter region of the DNA. CRISPRi has the ability to silence multiple genes at the same time. The authors research determined that dCas9 could be used to positively or negatively regulate the expression of particular target genes that influence cell differentiation. CRISPRi could therefore be useful to investigate stem cell differentiation pathways (Kearns et al,2014).